| 1 |
33091395 | Novel mutations in ATP13A2 associated with mixed neurological presentations and iron toxicity due to nonsense-mediated decay. | 2021 Jan 1 |
2 |
| 2 |
32032734 | Dysregulated iron metabolism in C. elegans catp-6/ATP13A2 mutant impairs mitochondrial function. | 2020 Jun |
4 |
| 3 |
29169913 | The strategic function of the P5-ATPase ATP13A2 in toxic waste disposal. | 2018 Jan |
1 |
| 4 |
26818499 | Regulation of ATP13A2 via PHD2-HIF1α Signaling Is Critical for Cellular Iron Homeostasis: Implications for Parkinson's Disease. | 2016 Jan 27 |
6 |
| 5 |
27073711 | Protection against Mitochondrial and Metal Toxicity Depends on Functional Lipid Binding Sites in ATP13A2. | 2016 |
1 |
| 6 |
25912790 | The Parkinson-associated human P5B-ATPase ATP13A2 protects against the iron-induced cytotoxicity. | 2015 Aug |
7 |
| 7 |
24361204 | C19orf12 mutation leads to a pallido-pyramidal syndrome. | 2014 Mar 10 |
1 |
| 8 |
22743658 | Analysis of ATP13A2 in large neurodegeneration with brain iron accumulation (NBIA) and dystonia-parkinsonism cohorts. | 2012 Aug 8 |
2 |
| 9 |
20310007 | ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation. | 2010 Jun 15 |
2 |
| 10 |
20740487 | Response to: ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation. | 2010 Oct 15 |
2 |
| 11 |
20817231 | Emerging parkinsonian phenotypes. | 2010 Oct |
1 |